foscarbidopa/foslevodopa

FDA Drug Profile — Vyalev

Drug Details

Generic Name
foscarbidopa/foslevodopa
Brand Names
Vyalev
Application Number
NDA216962
Sponsor
Patheon Manufacturing Services LLC
NDC Codes
2
Dosage Forms
INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
FOSCARBIDOPA, FOSLEVODOPA

Indications and Usage

1 INDICATIONS AND USAGE VYALEV is indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). VYALEV is a combination of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. ( 1 )